Most lately, it has been determined that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in similar places as classical opioid receptors, it binds to the wide array of endogenous opioids. Compared with most opioid receptors, this receptor acts as being a scavenger and won't activate a 2nd messenge